A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM
Giuseppe Paolisso(University of Naples Federico II), Éric Ravussin(National Institute of Diabetes and Digestive and Kidney Diseases), Barbara V. Howard(Georgetown-Howard Universities Center for Clinical and Translational Science), James E. Foley(National Institutes of Health), C. Bogardus, P. Antonio Tataranni(Università Cattolica del Sacro Cuore)
Cited by 352
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber.
|Journal of Clinical Investigation|1986|1.2k
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
|Circulation|2009|1.1k